Jason brings with him a wealth of life sciences experience and strong business networks, especially in Europe. He is an accomplished life sciences practitioner with over two decades of experience in various areas within the sector including drug development, drug discovery, management consulting, venture capital, strategy consulting and corporate finance advisory.

Jason joined Xeraya Capital from Deloitte Geneva, Switzerland, where for five years he was the Director, Corporate Finance Advisory, leading the firm’s healthcare and life sciences advisory (M&A) business. Before joining Deloitte he spent a short period as a independent strategy consultant.

His working career in the venture capital industry began with the Merlin Biosciences Fund and later with the Inventages (Nestlé) Fund where he sourced, evaluated and closed numerous venture capital investments and was involved in post investment management of portfolio companies, including taking on board positions. Prior to that Jason was a management consultant in the Life Sciences Group of PA Consulting. His early career was in the sciences, initially in drug development with Medeva Group and Cortecs Ltd, and later in drug discovery with Eli Lilly.

Jason holds a Master of Science degree in Immunology, and a Bachelor of Science (Hons) degree in Anatomy, both from the University of Birmingham, UK.